Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes - Seite 2
The parenteral formula market is mainly pushed by rising chronic illnesses like HIV, Crohn's disease, and cancer. The market is also augmented by extensive research & development efforts of leading firms to create new parenteral nutrition products.
Lesen Sie auch
Scope of the Parenteral Formula Market Report
Attribute |
Details |
||
Parenteral Formula Market Size (2024) |
US$ 6.8 billion |
||
Parenteral Formula Market Forecast Value (2034) |
US$ 12.5 billion |
||
Global Growth Rate |
5.7% CAGR |
||
Forecast Period |
2024 to 2034 |
||
Historical Data Available for |
2019 to 2023 |
||
Market Analysis |
US$ billion for Value |
||
Key Countries Covered |
• United States • Brazil • Mexico • Germany • UK • France • Italy |
• Spain • Nordic • Poland • China • India • Thailand • Indonesia |
• Russia • Canada • Australia and New Zealand • Japan • GCC countries |